Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,300 | 2 | 58.7% |
| Food and Beverage | $3,240 | 146 | 35.9% |
| Travel and Lodging | $376.97 | 4 | 4.2% |
| Gift | $106.64 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $6,931 | 72 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $789.22 | 30 | $0 (2024) |
| ABBVIE INC. | $273.08 | 12 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $249.77 | 8 | $0 (2024) |
| RedHill Biopharma Inc. | $194.99 | 8 | $0 (2024) |
| Ardelyx, Inc. | $140.33 | 5 | $0 (2024) |
| Braintree Laboratories, Inc. | $106.64 | 2 | $0 (2019) |
| NESTLE HEALTHCARE NUTRITION INC. | $58.68 | 3 | $0 (2023) |
| Concordia Pharmaceuticals Inc. | $39.98 | 2 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $39.65 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $709.33 | 23 | Phathom Pharmaceuticals, Inc. ($249.77) |
| 2023 | $154.59 | 7 | Gilead Sciences, Inc. ($114.56) |
| 2022 | $269.48 | 14 | Gilead Sciences, Inc. ($223.56) |
| 2021 | $336.17 | 17 | AbbVie Inc. ($163.10) |
| 2020 | $563.51 | 33 | Gilead Sciences, Inc. ($239.34) |
| 2019 | $3,269 | 31 | Gilead Sciences, Inc. ($2,834) |
| 2018 | $493.97 | 18 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($286.55) |
| 2017 | $3,228 | 11 | Gilead Sciences Inc ($3,160) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: LIVER DISEASE | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | Cash or cash equivalent | $57.86 | General |
| Category: Antibiotic | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Gastroenterology | ||||||
| 08/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/03/2024 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $11.49 | General |
| Category: GERD | ||||||
| 06/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Immunology | ||||||
| 04/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/16/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: VIROLOGY | ||||||
| 04/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $123.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/02/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Gastroenterology | ||||||
| 02/29/2024 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: Gastroenterology | ||||||
| 02/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $101.05 | General |
| 07/26/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/27/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.96 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,197 | 1,258 | $612,710 | $121,755 |
| 2022 | 10 | 1,241 | 1,322 | $624,770 | $121,038 |
| 2021 | 10 | 1,205 | 1,304 | $602,170 | $117,032 |
| 2020 | 9 | 888 | 952 | $446,960 | $83,551 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 163 | 163 | $130,400 | $26,598 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 243 | $48,600 | $24,000 | 49.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 199 | 199 | $159,200 | $14,921 | 9.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 198 | 205 | $153,750 | $14,710 | 9.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $30,300 | $13,211 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 174 | 206 | $22,660 | $12,607 | 55.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 75 | 75 | $15,000 | $6,145 | 41.0% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2023 | 31 | 31 | $24,800 | $5,886 | 23.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $14,400 | $3,451 | 24.0% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $13,600 | $225.08 | 1.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 242 | 279 | $55,800 | $25,850 | 46.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 167 | 167 | $133,600 | $24,623 | 18.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 205 | 209 | $156,750 | $14,751 | 9.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 192 | 232 | $25,520 | $13,954 | 54.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 107 | 107 | $32,100 | $12,862 | 40.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 186 | 186 | $148,800 | $12,438 | 8.4% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2022 | 45 | 45 | $36,000 | $8,449 | 23.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 69 | 69 | $13,800 | $4,979 | 36.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 15 | 15 | $12,000 | $2,956 | 24.6% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $10,400 | $176.47 | 1.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 149 | 149 | $119,200 | $22,931 | 19.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 210 | 246 | $49,200 | $20,316 | 41.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 142 | 142 | $42,600 | $15,736 | 36.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 213 | 215 | $161,250 | $15,152 | 9.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 191 | 252 | $27,720 | $13,341 | 48.1% |
About Fang Yu
Fang Yu is a Internal Medicine healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497869630.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Fang Yu has received a total of $9,024 in payments from pharmaceutical and medical device companies, with $709.33 received in 2024. These payments were reported across 154 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($5,300).
As a Medicare-enrolled provider, Yu has provided services to 4,531 Medicare beneficiaries, totaling 4,836 services with total Medicare billing of $443,377. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Irvine, CA
- Active Since 08/17/2006
- Last Updated 01/28/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1497869630
Products in Payments
- Vemlidy (Drug) $6,051
- XIFAXAN (Drug) $521.23
- VOQUEZNA (Drug) $249.77
- TRULANCE (Drug) $164.80
- LINZESS (Drug) $159.35
- IBSRELA (Drug) $140.33
- SUPREP BOWEL PREP (Drug) $106.64
- XIFAXANIBSD (Drug) $106.05
- Talicia (Drug) $99.97
- Movantik (Drug) $72.66
- MAVYRET (Drug) $63.36
- ZENPEP (Drug) $58.68
- DONNATAL (Drug) $39.98
- CREON (Drug) $28.04
- TREMFYA (Drug) $23.64
- Cologuard Collection Kit (Device) $23.26
- Aemcolo (Drug) $22.36
- PREPOPIK (Drug) $22.28
- Mulpleta (Drug) $20.85
- CapsoCam Plus (Device) $20.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Irvine
Dr. Tung Ngo, Do, DO
Internal Medicine — Payments: $4.9M
Rashmi Kumar, Md, MD
Internal Medicine — Payments: $121,958
Dr. Irene Kang, M.d, M.D
Internal Medicine — Payments: $55,000
Dr. Behdad Akbarpour, Md, MD
Internal Medicine — Payments: $34,097
Dr. Maher Kassis, M.d, M.D
Internal Medicine — Payments: $30,310
Dr. Shanta Chawla, Md, MD
Internal Medicine — Payments: $17,484